Molecular response of CSF3R T618I harboring chronic neutrophilic leukemia after induction chemotherapy linked to cord blood transplantation

Kawashima, Ichiro; Kumagai, Takuma; Suzuki, Megumi; Suzuki, Jun; Koshiishi, Megumi; Nakajima, Kei; Kirito, Keita

doi:10.1007/s00277-019-03733-8

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…(3,4) CSF3R mutations (CSF3R mut ), in particular the T618I, were identified in approximately 80% of patients diagnosed with CNL and served as a disease-specific genetic markers for CNL. (3,(5)(6)(7) However, this mutation was not observed in myelodysplastic/myeloproliferative neoplasms (MDS/MPN) (8), and was uncommon in chronic myelomonocytic leukemia (CMML). (9) The frequency of CSF3R mut was reported to be 3% in intermediate-risk karyotype acute myeloid leukemia (AML), 1.9% to 3.6% in pediatric AML and 1% in adult AML.…”

Section: Introductionmentioning

confidence: 99%

Differential Implications of CSF3R Mutations in t(8;21) and CEBPA Double Mutated Acute Myeloid Leukemia

Wang

Wen

Wang

et al. 2022

Clinical Lymphoma Myeloma and Leukemia

View full text Add to dashboard Cite

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

show abstract